Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) — Detroit, Michigan

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer, Urothelial Carcinoma.

Sponsors: Fujifilm Pharmaceuticals U.S.A., Inc., Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)?

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) conducted?

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) has 5 clinical trials on record, with 5 currently active. Their work covers Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer, Urothelial Carcinoma.

Is Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) accredited by Crixeo Health?

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.